Research Progress on the Effect of Traditional Chinese Medicine on Signal Pathway Related to Premature Ovarian Insufficiency

Wang, Yidi; Teng, Xiuxiang; Liu, Jun

doi:https://doi.org/10.1155/2022/7012978

Evidence-Based Complementary and Alternative Medicine

On this page

Abstract Introduction Conclusion Data Availability Conflicts of Interest Authors’ Contributions Acknowledgments References Copyright Related Articles

Special Issue

Complementary and Alternative Medicine in Reproductive Endocrine Diseases 2021

View this Special Issue

Review Article | Open Access

Volume 2022 | Article ID 7012978 | https://doi.org/10.1155/2022/7012978

Research Progress on the Effect of Traditional Chinese Medicine on Signal Pathway Related to Premature Ovarian Insufficiency

Yidi Wang,^1,2Xiuxiang Teng ,²and Jun Liu²

Academic Editor: Tian-Bo Liu

Received18 Apr 2022

Accepted02 Aug 2022

Published14 Sept 2022

Abstract

The occurrence and development of premature ovarian insufficiency involves the abnormality of multiple signal pathways. It is a complex disease. Traditional Chinese medicine affects the relevant factors of the occurrence and development of premature ovarian insufficiency (granulosa cell apoptosis, ovarian blood supply, ovarian reserve, ovarian oxidative damage, gap junction, ovarian fibrosis, follicular development, follicular atresia, and other biological processes) by regulating a variety of signal pathways, thus playing the role in antioxidant stress, prevention and treatment of chemotherapy side effects, protection of ovarian function, control of aging, and improvement of ovarian reserve function. The research shows that the research on the related pathways of traditional Chinese medicine in the treatment of premature ovarian insufficiency has been quite extensive. Based on the search of the domestic and foreign literature, it is found that Yulinzhu and Xianziyizhen capsule and ginsenoside Rg₁ can promote the proliferation and differentiation of granulosa cells, inhibit apoptosis, and reduce follicular atresia by affecting the PI3K/Akt/mTOR signal pathway; Guiluo's Anzang decoction, Kuntai capsule, and Yangyin Shugan granule can maintain the balance between pro-apoptotic protein and anti-apoptotic protein through the Bax/cytc/caspase-3 pathway to improve ovarian reserve function; Bushen Jianpi recipe can control cell apoptosis and promote the proliferation and development of ovarian granulosa cells by regulating the MAPK signal pathway; Siwu mixture and Zuo Gui pill can regulate the TGF-β/Smads signaling pathway to promote the recruitment of primordial follicles, promotes follicular development, inhibits follicular atresia, and regulates ovarian function; Erxian decoction, Yiqi Yangrong Fujing formula, and Cistanche deserticola can antagonize the inflammatory symptoms of premature ovarian failure, promote the secretion of relevant vascular growth factors, and enhance the ovarian reserve function through the NF-KB signal pathway; Bushen Culuan decoction can promote damage repair and protect normal ovarian cells through antioxidant stress. The above summary aims at providing reference for the in-depth study of traditional Chinese medicine in the treatment of premature ovarian insufficiency and inspiring new diagnosis and treatment ideas.

1. Introduction

Premature ovarian insufficiency (POI) is defined as a decline in ovarian function that occurs in women before the age of 40 years, resulting in abnormal menstruation, increased FSH levels, decreased estrogen volatility, and decreased fertility. Clinical female patients will have hot flashes, sweating, vaginal dryness, mood changes, and fertility difficulties. POI also increases a woman’s risk of osteoporosis, and cardiovascular and cognitive disorders, according to related studies. Thus, the decline of ovarian function seriously reduced the patient's quality of life. At present, the incidence of POI is 1%∼65% and has a tendency to increase. Its pathogenesis is also not clear in the existing guidelines, and expert consensus suggests that treatment with hormone replacement therapy is given priority and can effectively relieve the clinical symptoms, but the side effect is more apparent, such as patients with uterine using estrogen therapy may increase the risk of endometrial cancer. Estrogen and progesterone can increase the risk of ovarian cancer [1]. Therefore, it is important to find nonhormone replacement therapy.

Traditional Chinese medicine treatment is characterized by syndrome differentiation and treatment, which varies from person to person and has few side effects. In traditional Chinese medicine, POI can be classified into “amenorrhea,” “infertility,” and “blood depletion” [2]. The pathogenesis is mostly due to the deficiency of Yin and blood in the kidney, in combination with liver depression, spleen deficiency, dampness and heat, vein stasis, etc. The treatment of TCM is mainly based on the principles of nourishing Yin and blood, warming the kidney Yang, relieving liver depression, strengthening the spleen, benefiting Qi, activating blood stasis, , and focusing on comprehensive treatment by identification. With the continuous research and excavation of TCM, more and more reports point out that TCM can treat POI through multiple pathways and targets. On this basis, the author collated the domestic and foreign literature in recent years to summarize the pathways of TCM in the treatment of POI and to provide a basis for clinical use.

2. PI3K/Akt Signaling Pathway

Phosphatidylinositol 3-kinase (PI3K) signaling pathway is the basic signaling pathway in animals, playing an indispensable role in cell growth, proliferation, survival, migration, metabolism, and apoptosis [3]. Studies in recent years have revealed that the PI3K/Akt pathway also plays an important role in premature ovarian insufficiency. For example, the PI3K/Akt/mTOR signaling pathway has a regulatory role in the HPG axis [4], and the activated Akt pathway further causes a cascade reaction of signaling pathway, and phosphorylated Akt can phosphorylate a series of downstream target proteins. It includes FOXO3a (antiproliferation and apoptosis), BAD (a pro-regulatory member of the Bcl-2 family, involved in cellular mitochondrial regulatory pathways), mTOR (which controls protein biosynthesis and regulates cell growth), and P27 (which maintains primal follicular reserves).

2.1. PI3K/Akt/mTOR Signaling Pathway

The complex TSC1/2 is both an oncogene and a major inhibitor of mTORC1. Elevated AKT expression promotes the separation of the complex TSC1/2, and the dissociation of the two releases the inhibition of mTORC1 and activates mTORC1, thus allowing the activation of the mTOR signaling pathway. The mTOR activation can inhibit autophagy and thus promote cellular senescence.

A nonrandomized noninferiority controlled study [5] conducted by Teng Xiuxiang et al. found that after treatment with Yulinzhu plus reduction in the treatment group, compared to the control group treated with estradiol valerate tablets plus progesterone capsules, the treatment group had significantly better overall efficacy (61.54%) and TCM evidence efficacy (49.45%), and serum FSH, LH, and E₂ were significantly improved compared to the control group. One study reported [6] that after immune POI mice were given the Chinese herbal medicine Yulinzhu for 6 weeks, Akt protein expression was significantly increased and TSC1 and TSC2 protein expression was significantly decreased in each administration group. RheB, P-s6k1, and P-4E-BP1 protein expressions were elevated, with P-4E-BP1 being the most significantly elevated, ROS and MDA were significantly elevated, and GSH-Px and SOD were significantly decreased, indicating that Yulinzhu inhibits microenvironmental oxidative stress by regulating the TSC/Akt signaling pathway.

A randomized controlled trial [7] conducted by Lin Xiuqin found that the total response rate of Jiajian Guishen pill combined with estradiol valerate tablets and progesterone capsules in the observation group and estradiol valerate tablets and progesterone capsules in the control group was 93.33% and 70%, respectively, with statistically significant differences. In a study by Kong [8], it was found that Jiajian Gui Shen pill was able to increase the number of follicles at all levels in the ovaries of VCD-induced mice, reduce atretic follicles, improve serum sex hormone levels, and also improve ovarian function possibly by upregulating PI3K, Akt, mTOR mRNA, and protein expression levels.

Huang et al.[9] showed that the Xianzi Yizhen capsule was able to increase Ki-67, Akt, and PI3K protein expression and concluded that the mechanism of improving ovarian function might be related to increased PI3K/Akt pathway activity and cell proliferation status in ovarian cells, which increased the content of primordial follicles, secondary follicles, and sinusoidal follicles and decreased the content of atretic follicles.

Ginsenoside Rg1 is an important pharmacologically active component of ginseng, which has the ability to promote the secretion of estrogen and luteinizing hormone (LH). Liu et al.[10] observed that ginsenoside Rg1 can effectively inhibit the expression of PI3K, Akt, mTOR, and S6k proteins compared to the high expression of PI3K, Akt, mTOR, and S6k proteins in aging tissues, indicating that ginsenoside Rg1 can negatively regulate the PI3K/Akt/mTOR signaling pathway and activate autophagy in ovarian tissues, thereby inhibiting the onset of aging and prolong lifespan.

Icariin is a flavonoid extracted from Epimedium, which has phytoestrogen-like effects. Dong [11] found that Epimedium phosphorylated the activation of PI3K/Akt/mTOR signaling pathway-related proteins during the development of chemotherapy-injured POF, inhibited oxidative stress to reduce tissue apoptosis, and improved chemotherapy-injured POF in mice.

Thus, the PI3K signaling pathway not only regulates the growth of oocytes, regulates the survival and development of primordial follicles, and promotes the proliferation and differentiation of granulosa cells, but also inhibits apoptosis, which is crucial for the normal development and physiological function of ovaries.

2.2. Bax/CytC/Caspase-3

Bcl-2 and Bax are a pair of anti-apoptotic proteins that are antagonistic to each other. Bcl-2, which is mainly found in the outer mitochondrial membrane and part of the endoplasmic reticulum, can play its role in inhibiting apoptosis by blocking the release of mitochondrial CytC and then preventing the activation of caspase apoptosis protein. When cells receive apoptotic signals, Bax translocates into the mitochondria and exerts its pro-apoptotic effect by promoting the release of CytC in large amounts and further initiating the caspase cascade reaction. Whether the cells continue to survive or go to death depends to some extent on the ratio of Bcl-2 to Bax.

Yi-Hui observed [12] that Gui Luo’s Anzang decoction could increase Bcl-2 protein expression and decrease Bax protein expression in the ovary, reduce granulosa cell apoptosis, and increase granulosa cell secretion.

A meta-analysis of a randomized controlled trial [13] conducted by Liu et al. showed that the total effective treatment rate of Kuntai capsules combined with hormonal therapy for POF was significantly better than that of hormonal therapy alone (OR = 3.76, 95% CI [2.65, 5.35], ). In an experiment, Geng [14] observed that the Kuntai capsule could improve ovarian reserve by downregulating the levels of FSH and LH, stimulating E₂ secretion, regulating the Bcl-2/Bax ratio among Bcl-2 family protein members, and upregulating the expression of Bcl-2 and Bcl-xl proteins versus downregulating the expression of Bax and Bad proteins to maintain the balance between pro-apoptotic and apoptosis-inhibiting proteins.

Wang [15] found that Yangyin Shugan granule could regulate the expression levels of apoptosis-related proteins in ovarian tissues, increasing the expression of Bcl-2 protein and decreasing the expression of Bax and caspase-3 proteins, thus inhibiting apoptosis.

A systematic evaluation [16] conducted by Hu et al. showed that the efficacy of Zuo Gui pill combined with western artificial cycles was superior to treatment with western artificial cycles alone for premature ovarian failure, with significant advantages in the combined group in terms of improved menstrual rates and improved values of serum FSH, and Wang [17] and Gao [18] found through experiments that Zuo Gui pill could increase the level of Bcl-2 mRNA and decrease the level of Bax, and Bcl-2>Bax, concluding that the kidney Zuo Gui pill may inhibit chemotherapy-induced granulosa cell apoptosis by affecting the expression levels of apoptotic factors Bcl-2 and Bax, and thus play a role in protecting ovarian function.

2.3. FOXO3 Transcription Factor-P27/Bim

FOXO3 is an important transcription factor downstream of the PI3K/Akt pathway. When the Akt pathway is inhibited, dephosphorylated FOXO3 enters mostly into the nucleus and accelerates cell regulation. FOXO3 together with RUNX3 binds to the Bim gene in order to activate Bim and thus induce cell regulation.

A randomized controlled trial [19] conducted by Xiao et al. found that in POI, the clinical efficacy of Erxian decoction (95.00%) was significantly better than that of the estradiol valerate combined with the progesterone group (77.50%). In an experiment, Zhao [20] observed that Erxian decoction had a protective effect on cisplatin-injured ovarian granulosa cells. On the one hand, it may be that Erxian decoction exerts a pro-proliferative effect by affecting the granulosa cell cycle phase, promoting the transformation of granulosa cells from G₀ to S phase, decreasing the proportion of G₀ phase cells, increasing the ratio of S phase cells, and improving the proliferation index; on the other hand, it may be that Erxian decoction exerts an antiregulatory effect by decreasing the rate of cisplatin-induced granulosa cell apoptosis. And it was further found that the protective effect of Erxian decoction on cisplatin-induced ovarian granulosa cells might be achieved by regulating the expression of FOXO3a and its downstream target proteins. Thus, Erxian decoction can downregulate the expression of FOXO3a in cisplatin-injured granulosa cells, which in turn downregulates the expression of cell cycle blocker protein P27^kip1 and pro-apoptotic protein Bim, thus promoting granulosa cell proliferation and inhibiting granulosa cell regulation.

Yang [21] found that the intervention of Zuo Gui pill in the experiment may affect the p-Akt-to-Akt ratio by upregulating the p-Akt level on the PI3K/AKT pathway, as well as reducing FOXO3a protein expression, which in turn effectively inhibits granulosa cell damage and prevents premature follicular failure and atresia in order to protect ovarian function.

In addition, Yangyin Shugan granule could regulate the expression levels of PI3K/Akt/FOXO3a pathway-related proteins in ovarian tissues, increasing the expression of PI3K and Akt proteins, and decreasing the expression of FOXO3a proteins.

3. MAPK Signaling Pathway

PTEN is involved in apoptosis through several signaling pathways, among which the activation of MAPK/ERK and PI3K/Akt signaling pathways is more common, and there are also interactions between PI3K/Akt and MAPK/ERK signaling pathways [22]; PTEN proteins can negatively regulate the activation of Raf1 by Ras in the MAPK/ERK pathway by activating Akt in the PI3K/Akt pathway, and can also directly negatively regulate Raf1 in the absence of Ras action, which in turn inhibits the biological effects of MAPK/ERK and promotes apoptosis.

MAPK pathway has an important role in inflammation, stress response, and apoptosis of cells. Among MAPK signaling pathways, extracellular signal-regulated kinase (ERK) regulates the inflammatory response and also regulates the stem cell factor (SCF)/tyrosine kinase receptor (c-kit) signaling pathway [23]. The MAPK pathway regulates apoptosis by a complex mechanism [24], at least through the following pathways: enhancement of c-Myc expression, phosphorylation of P53, involvement in Fas/Fasl-mediated apoptosis, activation of c-jun and c-fos, and induction of Bax translocation. In addition to the above five pathways, p38 MAPK can also induce apoptosis by enhancing TNF expression.

3.1. ER/C-MYC/TERT Signaling Pathway

Estrogen can regulate the expression of the TERT gene. c-Myc is the target gene of the estrogen receptor (ER). Estrogen binding to ER promotes the expression of transcription factor c-Myc. c-Myc can bind directly to the E-box at the 5′ end of the core promoter of the TERT gene of many cellular telomerases, which promotes TERT gene transcription, thereby activating telomerase and maintaining normal cellular function [25–27].

A randomized controlled trial [28] conducted by Chen found that Bushen Jianpi decoction was 93.30% effective in treating POI. Wang et al.[29, 30] observed that by increasing E₂ levels, promoting ER activation, and stimulating c-Myc expression, Bushen Jianpi decoction can increase ovarian telomerase activity and telomere length, which in turn regulates TERT expression, thereby promoting proliferation and development of ovarian granulosa cells and maturation of oocytes.

3.2. P53

P53, as an oncogene, is located in the nucleus and can bind specifically to DNA, which can be activated when DNA is damaged, causing cells to be blocked in the G₁ phase, and if the damaged DNA cannot be repaired, P53 can contribute to the apoptosis of damaged cells, and high expression of P53 heralds the cessation of cell growth or apoptosis [31].

A randomized controlled trial [32] carried out by Yanjin et al. found that the effective rate of Bushen Tiaochong decoction in treating POI reached 97.90%. Zhang [33] observed that the mechanism of Bushen Tiaochong decoction mainly can significantly improve the sex hormone level in mice, significantly increase the level of E₂ and AMH, and decrease the level of FSH and LH; downregulate the expression of P53, while upregulate the expression of GnRHR, prolong the time of apoptosis, reduce the occurrence of follicular atresia, improve the reserve capacity of ovarian receptors, and then, coordinate ovarian function.

3.3. Ki67/ERK

Ki67 protein is expressed in the nucleus, is closely associated with mitosis, and plays an important role in cell proliferation [34].

A randomized controlled trial [35] conducted by Wu found that the overall effective rate of Bushen Huoxue decoction in treating POI was 93.33%. Zonghui [36] found that Bushen Huoxue decoction increased p-ERK1/2 protein levels in the ovarian tissue of aged mice, activated ERK1/2 phosphorylation, further improved follicular development in mice with decreased ovarian reserve function at advanced age, and increased the proliferation of follicular granulosa cells and granulosa cells of the oocyte complex.

3.4. p-38/Fas/FasL

The Fas/FasL pathway, also known as the death receptor pathway, acts as an apoptotic signaling receptor, forming a death-inducing complex by binding to its ligand FasL and activating its downstream caspase-3 to induce apoptosis [37].

Chunling [38, 39] showed that the Kuntai capsule could repair pathological damage to ovarian function in fertile rats, regulate serum sex hormone levels in mice with POF, downregulate FSH and LH levels, FasL protein, and mRNA expression, upregulate E₂ and AMH levels, and Fas protein mRNA expression, and increase Fas mRNA expression and FasL mRNA expression to increase Fas mRNA expression and decrease FasL mRNA expression, thus protecting and improving ovarian function. In addition, the Kuntai capsule can improve the reproductive function of mice and increase the conception rate and pregnancy rate of mice with POF, and has no significant teratogenicity to the offspring mice.

Dan [40] found that the Gui Zhi Fu Ling capsule could significantly improve sex hormone levels in mice with POF, with the best effect in the middle dose group, which may be related to the inhibition of the Fas/FasL signaling pathway and reduction of ovarian cell apoptosis.

3.5. SCF

Stem cell factor (SCF), also known as Kit ligand, is a granulocyte-derived growth factor that binds to the oocyte c-Kit receptor and its signal is transduced through the PI3K channel.

Sun et al.[41] found that Zuo Gui pill upregulated Cx43 mRNA and protein expression in ovarian tissues of CTX-induced POF mice, increased the distribution of Cx43 between follicles and granulosa cells, and improved gap junction function.

Xinpeng [42] found that Bushen Tiaochong decoction promoted ovulation by increasing the sensitivity of ovaries to gonadotropins; by upregulating the expression of Cx-37 and downregulating the expression of SCF, it promoted the growth and development of early follicles and improved the gap junction function of ovarian tissues in rats and thus repaired ovarian functional damage. Xiang [43] found that Kun Bao pill reduced ovarian fibrosis by decreasing the expression of CTGF, TGF-β1, and SCF, which showed that Kun Bao pill had a positive intervention effect on POF induced by cisplatin injection in mice.

4. TGF-β/Smads Signaling Pathway

TGF-β/Smads signaling is an important transduction pathway that regulates follicular development, and abnormalities in either process of the transduction pathway may cause signaling disorders, leading to impaired follicular recruitment, inhibition of follicular growth and development, accelerated follicular atresia, and premature ovarian failure.

A randomized controlled trial [44] conducted by Liu Jia found that the total effective rate after treatment was 92.68% in the observation group and 81.71% in the control group when the observation group was given the combination of Siwu mixture combined with hexestrol and medroxyprogesterone acetate. Hongbo [45] found that Smad2/3 protein is an upstream regulatory signaling protein of Cyp19a1 through experiments, and by detecting Smad2/3 protein and its phosphorylated protein PSmad2/3, it was found that Siwu mixture upregulated Cyp19a1 expression by promoting the expression of Smad2/3, a Cyp19a1 regulatory protein.

Yameng [46] found that the Kuntai capsule could not only reduce the levels of sex hormones FSH and LH, increase the levels of E₂ and AMH, repair the damaged ovarian tissue structure, improve ovarian blood supply, promote the development of rats follicles, reduce follicular atresia, and increase the number of mature follicles present, but also increase the expression of GDF-9 and EGR-1 protein and mRNA in rats ovaries. Chen [47] found that the Kuntai capsule may increase the expression of FSHR in rats’ ovarian tissue by upregulating the expression of Smad2/3, improve the responsiveness of ovaries to FSH, promote follicle development, and reduce the level of serum FSH; meanwhile, it downregulates the expression of Smad7 in rats ovarian tissue to reduce follicle apoptosis, maintain follicle growth and development, and improve ovarian function in rats.

Zhu [48] found that Zuo Gui pill could upregulate the protein expression levels of ovarian GDF-9 and its signaling protein Smad2 in POF mice and promote the development of growing follicles in Smad2 mice. Compared with the model group, the ovarian GDF-9 and Smad2 protein expression increased and the ratio of ovarian growth follicles increased in the Zuo Gui pill group, suggesting that Zuo Gui pill may regulate ovarian function by improving the regulation of GDF-9/Smad2 signaling, thereby promoting the recruitment of initiating follicles, promoting follicular development, and inhibiting follicular atresia.

In addition, Yu [49] found that TCM tonic kidney and filling essence method could activate the Bmps/Smad signaling pathway, thus initiating primordial follicle development, inhibiting oocyte apoptosis, and improving ovarian function. Huiping [50] found that Bushen Huoxue decoction not only regulated follicle development and promoted granulosa cell proliferation related to the ActA/Smads pathway, but also promoted estradiol E₂ secretion through the TGF-β1/Smads pathway to improve the local microenvironment of the ovary.

5. NF-KB Signaling Pathway

The NF-kB family plays an important role in physiopathological processes such as inflammation and immune response, oxidative stress response, cell proliferation, and apoptosis by regulating the expression of various pro-inflammatory factors, growth factors, and adhesion molecules. It has been reported [51] that NF-kB induces the expression of several pro-inflammatory factors, such as TNF-α, IL-β, FGF, VFGF, CINC1, and ICAM1.

5.1. The TNF-α

TNF-α is a multireactive cytokine that induces apoptosis of granulosa cells or early follicles by autocrine or paracrine means, and also causes vascular endothelial damage and inhibits hormone secretion and follicle growth and development.

In the rats with POF, the protein and gene expression of TNF-α and IFN-γ were increased in ovarian tissues, and IFN-γ could induce enhanced expression of MHC antigens on granulosa cells and activate a series of cytokines such as IL-1, IL-2, TGF-β, TNF-α, and FGF to produce autoimmune responses to cause follicular atresia. TNF-α can cause vascular endothelial damage and affect local blood flow in the ovary, which can block hormone secretion and follicular growth and development at all levels. After the intervention of renal tonic drugs, the expression levels of TNF-α and IFN-γ decreased, the expression of Bcl-2 protein increased, the expression of Bax protein decreased, and the apoptosis of granulosa cells was inhibited.

Zhou [52] observed that Erxian decoction could antagonize inflammatory symptoms in a dose-dependent manner in rats with POF, and could promote the secretion of vascular growth factors associated with POF and enhance ovarian reserve function.

Liu et al.[53] found that Cistanche can reduce follicular atresia and apoptosis by regulating sex hormone levels and inhibiting the expression of TNF-α and IFN-γ in rats, thus slowing down ovarian failure; Cistanche can also upregulate Bcl-2/Bax, suggesting that Cistanche has an inhibitory effect on POF, and the mechanism may be related to ovarian sex hormone levels, TNF-α, IFN-γ, and apoptosis-related protein Bcl-2/Bax expression.

Lan et al. [54] found that the Chinese herbal Fufang Yiqi Yangrong Fujing formula could effectively regulate serum LH, FSH, and E2 levels in CTX-induced POF mice and improve pituitary and ovarian endocrine functions. It could also increase the expression levels of serum IL-2 and TNF-α, inhibit the apoptosis of ovarian granulosa cells, restore ovarian function, and enhance ovarian reserve capacity.

5.2. VEGF and bFGF

Ovarian blood flow is an important factor in maintaining follicular growth, steroid hormone secretion, and follicular sensitivity to gonadotropins. The VEGF and bFGF are vascular endothelial growth factors, which can repair damaged follicles and improve damaged ovarian vascular permeability and can specifically promote cell proliferation survival and chemotaxis in steroid hormone-producing organs and promote neovascularization. The bFGF plays an important role in luteinizing, mainly in promoting the growth and development of follicular corpus luteum, and also in providing nutrition to the corpus luteum entity.

Xu [55] found that Bushen Tiaochong decoction could prevent the occurrence of premature ovarian failure in rats, and its mechanism of action might be related to the positive effect of certain components in Chinese medicine in the enhancement of gonadotropins, which promotes the repair of ovarian function and improves ovarian function. Serum FSH and LH were decreased, and E₂ was increased in rats with premature ovarian failure by Chinese medicine gavage, and the expression of the VEGF and the bFGF in ovarian tissues was increased [56], and the expression of TNF-α and IFN-γ was downregulated to reduce follicular atresia and slow down the depletion of follicles.

In addition, the expression of VEGF and bFGF was significantly increased in rats with POF after gavage of Kuntai capsules () [57]. This indicates that Kuntai capsules can protect vascular endothelial cells, smooth blood flow in the ovaries, improve ovarian reserve capacity, and prevent POF. By regulating hormone levels and upregulating the expression of VEGF and bFGF mRNA to alleviate the damage to ovarian function caused by Leigongteng polysaccharide tablets, it delayed or blocked POF, promoted follicle development, and improved ovarian function.

6. Keap1 Nrf2/ARE Pathways

Oxidative stress is one of the key factors leading to apoptosis of oocytes and ovarian granulosa cells. The key pathway for cellular resistance to oxidative stress [58] is the Kelch-like epichlorohydrin-associated protein 1 (Keap1)-nuclear factor E2-related factor 2 (Nrf2)/antioxidant response element (ARE), which initiates antioxidant enzymes downstream of the pathway, including superoxide dismutase (SOD), quinone oxidoreductase, glutathione peroxidase (GSH-Px), and catalase (CAT) [59].

A randomized controlled trial [60] conducted by Ma et al. found that in patients with POI infertility, the test group used Bushen Culuan decoction and the control group used “estradiol valerate tablets + clomiphene + progesterone,” and the results showed that the ovulation rate, pregnancy rate, sex hormone level, and TCM symptoms score improved significantly better in the test group than the control group. The total effective rate of treatment in the trial group was 95.35%. Bushen Culuan decoction ameliorated the oxidative stress induced by raffinose polysaccharide [61], decreased the content of ovarian DNA oxidative damage product 8-OHdG and lipid peroxidation product MDA, elevated the activity of ovarian CAT, GSH-PX, SOD, and HO-1 antioxidant enzymes, and inhibited Keap1, through the Nrf2/ARE signaling pathway, and Bach1 nuclear protein expression and promoted Nrf2 nuclear translocation, thus activating downstream antioxidant enzyme activities, which in turn attenuated the ovarian oxidative damage induced by raffinose polysaccharide.

Yu-Zhi [62] observed that Yiguan Jian decoction not only could improve ovarian morphology and ovarian quality in a rat model of POF, but also could repair damaged and protect normal ovarian cells by mobilizing T-SOD and CAT, thus reducing the damage to ovarian cells by peroxidation-related substances such as MDA and caspase-3.

7. Ovarian Silencing Regulatory Proteins (SIRTs)

SIRTs are regulatory factors involved in the aging process. Early studies suggested [63] that SIRTl promotes follicle development, improves ovarian reserve function, and prolongs ovarian lifespan. SIRT1 inhibits the NF-KB inflammatory signaling pathway and reduces inflammatory factor release. It increases the expression of the anti-apoptotic protein Bcl-xl and downregulates the pro-apoptotic proteins caspase-3 and Bax, through the FOXO1 signaling pathway, and inhibits apoptosis.

Tong et al. [64] found that Zuo Gui pill and You Gui pill could increase follicle count, SIRT1, and serum AMH and INHB, and decrease serum LH and FSH concentrations in mice with POF, in addition to the fact that the number of primordial follicles in the You Gui pill group was significantly higher than that in the Zuo Gui pill group, indicating that Zuo Gui pill and You Gui pill had significant anti-ovarian aging effects, and their mechanism of action was related to the upregulation of ovarian SIRT1 expression.

The effects of single herbs and Chinese herbal formulas on the regulation of the POI signaling pathway are summarized in Tables 1 and 2.

8. Conclusion

Signaling pathways are used as enzymatic response pathways that can transmit molecular signals from outside the cell to the cell in order to function, and the pathogenesis of various diseases involves the participation of related signaling pathways. In recent years, research on TCM interventions in related signaling pathways has been on the rise, especially in TCM to further understand the pathogenesis of POI by studying interventions in the transmission of related signaling pathways. There are numerous pathways related to two major factors of POI: genetics and immunity. PI3K/Akt signaling pathway, TGF-β/Smads signaling pathway, and MAPK signaling pathway also restore ovarian function by regulating apoptosis, oxidative stress response, etc. In conclusion, Chinese herbal medicines alone or in combination can affect the factors related to the development of POI (granulosa cell apoptosis, ovarian blood supply, ovarian reserve, ovarian oxidative damage, gap junctions, ovarian fibrosis, follicular development, follicular atresia, and other biological processes) by regulating one or more signaling pathways, thus playing a role in antioxidative stress, preventing, and controlling the side effects of chemotherapy, protecting ovarian function, controlling the onset of aging, and improving ovarian reserve function. However, most of the current studies on signaling pathways related to TCM interventions are in their infancy, with relatively few studies and uncertain clinical efficacy. Therefore, further in-depth clinical studies are needed in the future, close to the clinic, to provide useful methods for the clinical treatment of POI patients.

Data Availability

The data that support the findings of this study can be obtained from the corresponding author upon reasonable request.

Conflicts of Interest

The authors declare they have no financial interest.

Authors’ Contributions

YDW was involved in the design and conduct of the review and drafting of the manuscript. Dr. JL was involved in revising the manuscript. Professor XXT validated the final version for submission and revised the manuscript.

Acknowledgments

This study was funded by Capital Health Development Research Special Project (2022-2-2233).

References

X. Chen, Y. F. Zhou, and B. Wen-Pei, “Research progress of the risk of tumors of menopausal hormone replacement therapy,” Journal of International Obstetrics and Gynecology, vol. 43, pp. 489–492+496, 2016.
View at: Google Scholar
J. Guo, X. Xiao, H. Y. Yao, D. Liu, W. Zhao, and X. X. Teng, “Professor Teng Xiu-Xiang’s experience in treating early-onset ovarian insufficiency from liver theory,” Chinese Journal for Clinicians, vol. 47, pp. 876-877, 2019.
View at: Google Scholar
J. Yang and J. L. Liang, “Progress in the study of PI3K/Akt signaling pathway associated with premature ovarian failure,” Progress in Obstetrics and Gynecology, vol. 25, no. 2, pp. 156–158, 2016.
View at: Google Scholar
F. Wang and K. Z. Xiao, “Regulatory effects of PI3K signaling on HPG Axis in mammalians,” Chinese Journal of Cell Biology, vol. 35, no. 7, pp. 1068–1072, 2013.
View at: Google Scholar
X. X. Teng, P. P. Li, H. Y. Yao, and J. J. Yuan, “Clinical research on modified Yulin Decoction in treating premature ovarian failure with syndrome of yang deficiency of spleen and kidney,” China Journal of Traditional Chinese Medicine and Pharmacy, vol. 32, no. 08, pp. 3849–3851, 2017.
View at: Google Scholar
M. L. Wei, Z. Yang, X. Y. Dong, and X. X. Feng, “Study on the regulation of TSC/Akt pathway by Yulinzhu to improve ovarian function in immune POI mice based on oxidative stress mechanism,” Global Traditional Chinese Medicine, vol. 14, no. 12, pp. 2127–2134, 2021.
View at: Google Scholar
L. Xiu-Qin, “Clinical study on adjuvant treatment of modified Guishen Wan on patients with premature ovarian failure,” Clinical Journal of Chinese Medicine, vol. 13, no. 36, pp. 61–63, 2021.
View at: Google Scholar
W. J. Kong, Systematic Evaluation of Kidney and Liver Tonification for Ovarian Reserve Hypofunction and its Effect on PI3K/AKT/mTOR Signaling Pathway, Beijing University of TCM, Beijing, China, 2020.
J. Y. Huang, M. Xu, Y. Y. Wang, D. T. Wen, and X. J. Lin, “Effect of shen-tonifying traditional Chinese herbs Xianzi yizhen capsules on PI3K/AKT signaling pathway of mice with premature ovarian failure,” Chinese Journal of Integrated Traditional and Western Medicine, vol. 38, no. 10, pp. 1203–1208, 2018.
View at: Google Scholar
X. H. Liu, Z. Zhao, Y. Zhou, C. L. Wang, Y. J. Han, and W. Zhou, “Effect of ginsenoside Rg₁ in delaying premature ovarian failure induced by D-gal in mice through PI3K/Akt/mTOR autophagy pathway,” China Journal of Chinese Materia Medica, vol. 45, no. 24, pp. 6036–6042, 2020.
View at: Google Scholar
R. X. Dong, Mechanism Research of Icariin Improves Chemotherapy-Induced Premature Ovarian Failure in Rats by Inhibiting Oxidative Stress, Shanghai University of TCM, Shanghai, China, 2019.
Z. Yi-Hui, “Effect of guiluoshi anzang decoction on bcl-2, Bax protein expression and granulosa cell apoptosis,” Premature Ovarian Failure Rats, Guangxi University of TCM, Nanning, China, 2019.
View at: Publisher Site | Google Scholar
W. Liu, T. N. Nguyen, T. V. Tran Thi, and S. Zhou, “Kuntai capsule plus hormone therapy vs. Hormone therapy alone in patients with premature ovarian failure: a systematic review and meta-analysis,” Evidence-based Complementary and Alternative Medicine, vol. 2019, Article ID 208580, 9 pages, 2019.
View at: Publisher Site | Google Scholar
L. H. Geng, Inquiring into the Mechanism of Kuntai Capsule Treating Decreasing Ovarian Reserve by the Regulation of Granular Cell Apoptosis, Nanjing University of TCM, Nanjing, China, 2017.
J. J. Wang, The Efficacy of Yangyin Shugan Granule in the Treatment of Diminished Ovarian Function and Drug Safety Evaluation, Guangzhou University of TCM, Guangzhou, China, 2018.
Y. Hu, X. U. Liang-zhi, and Z. L Tan, “Systematic review on Zuo Gui wan in treatment of premature ovarian failure,” China Journal of Traditional Chinese Medicine and Pharmacy, vol. 28, pp. 2305–2310, 2013.
View at: Google Scholar
X. Y. Wang, Effects of Zuogui Bolus-Containing Serum on Expression of Bcl-2 and Bax Protein in Rat Ovarian Granulose Cell, Gansu University of TCM, Lanzhou, China, 2017.
S. Gao, “Effects of Zuojiuwan on the expression of sex hormones and Bcl-2/Bax in mice with premature ovarian failure,” Shanxi Journal of Traditional Chinese Medicine, vol. 38, pp. 1306-1307, 2017.
View at: Google Scholar
L. I. Xiao, “Curative effect observation of modified erxian decoction in treatment of early-onset ovarian insufficiency with spleen-kidney yang deficiency syndrome,” Acta Chinese Medicine, vol. 33, pp. 1340–1344, 2018.
View at: Publisher Site | Google Scholar
D. Zhao, Exploring the Protective Mechanism of Erxian Tang on Cisplatin-Injured Rat Ovarian Granulosa Cells Based on FOXO3a Transcription Factor, Beijing University of TCM, Beijing, China, 2017.
J. Yang, The Protection Mechanism Study on Zuo Gui Pill-Contained Serum Repairs Cisplatin Induced Human Ovarian Granular Cells Damage via PI3K/AKT Signaling Pathway, Jinan University, Jinan, China, 2017.
J. W. Sun, Q. Xiang, Z. C. Liu, S. S. Xu, and D. Ding, “Effect of PTEN gene expression on apoptosis of thyroid cancer cells BCPAP and FTC133 and expression of ERK and AKT,” Journal of Kunming Medical University, vol. 42, pp. 23–30, 2021.
View at: Google Scholar
Y. Liu, Y. P. Tang, L. Liu et al., “Effects of Huoxue tongjiang decoction on esophageal motility, serum inflammatory factors and lower esophageal sphincter SCF/c-kit signaling pathway reflux esophagitis model rats,” Journal of Traditional Chinese Medicine, vol. 63, pp. 269–275, 2022.
View at: Google Scholar
B. C. Zhang and W. Zhang, “TNF, p38MAPK and apoptosis,” Foreign Medical Sciences, pp. 464–466, 2001.
View at: Google Scholar
T. W. Chu, D. E. MacNeil, and C. Autexier, “Multiple mechanisms contribute to the cell growth defects imparted by human telomerase insertion in fingers domain mutations associated with premature aging diseases,” Journal of Biological Chemistry, vol. 291, no. 16, pp. 8374–8386, 2016.
View at: Publisher Site | Google Scholar
M. Lu, K. Ding, G. Zhang et al., “MicroRNA-320a sensitizes tamoxifen-resistant breast cancer cells to tamoxifen by targeting ARPP-19 and ERRγ,” Scientific Reports, vol. 5, no. 1, p. 8735, 2015.
View at: Publisher Site | Google Scholar
S. V. Muralidharan, J. Bhadury, L. M. Nilsson, L. C. Green, K. G. McLure, and J. A. Nilsson, “BET bromodomain inhibitors synergize with ATR inhibitors to induce DNA damage, apoptosis, senescence-associated secretory pathway and ER stress in Myc-induced lymphoma cells,” Oncogene, vol. 35, no. 36, pp. 4689–4697, 2016.
View at: Publisher Site | Google Scholar
W. S. Chen, The Clinical Research and Mechanism Study of Treatment of Replenishing Kidney and Spleen Decoction in Premature Ovarian Failure, Nanjing University of TCM, Nanjing, China, 2015.
H. D. Wang, H. Y. Guo, Q. Wang et al., “Effect of bushen Jianpi formulation on ER/c-Myc/TERT signaling pathway in premature ovarian failure mice,” Journal of Nanjing University of Technology (Natural Science Edition), vol. 37, pp. 886–890, 2021.
View at: Google Scholar
H. D. Wang, W. Lu, H. Y. Guo et al., “Effects of Bushen Jianpi Formula on ovary telomeres in natural aging mice,” China Journal of Traditional Chinese Medicine and Pharmacy, vol. 36, pp. 5191–5194, 2021.
View at: Google Scholar
W. Er-Qing, Frontiers in Pharmacology—Signals, Protein Factors, Genes and Modern Pharmacology, Science Press, Beijing, China, pp. 396–399, 2008.
S. Yan-Jin, X. Xiu-zhu, F. Chun-Quan et al., “Clinical study of Bushen Tiaochong Decoction in treating of premature ovarian failure,” Cardiovascular Disease Electronic Journal of Integrated Traditional Chinese and Western Medicine, vol. 3, no. 18, pp. 154-155, 2015.
View at: Publisher Site | Google Scholar
Sa Zhang, Effect of BuShen and TiaoChong Fang Recipe on P53, GnRHR in Rats with Cyclophosphamide Induced Ovarian Reserve, North China University of Technology, Beijing, China, 2018.
C. Schlüter, M. Duchrow, C. Wohlenberg et al., “The cell proliferation-associated antigen of antibody Ki-67: a very large, ubiquitous nuclear protein with numerous repeated elements, representing a new kind of cell cycle-maintaining proteins,” Journal of Cell Biology, vol. 123, no. 3, pp. 513–522, 1993.
View at: Publisher Site | Google Scholar
Q. Wu, Clinical Observation on the Treatment of Kidney Deficiency and Blood Stasis Syndrome of Early Ovarian Dysfunction with Bushen Huoxue Decoction, Hunan University of Chinese Medicine, Changsha, China, 2021.
View at: Publisher Site
Q. Zong-Hui, Research on the Effects of Invigorating Kidney and Removing Blood Stasis Recipe on the Follicular Development and Ovarian’s ERK Signal in Advanced-Age Mice with Decline in Ovarian Reserve, Anhui University of TCM, Hefei, China, 2017.
D. Peroumal, T. Abimannan, R. Tagirasa et al., “Inherent low Erk and p38 activity reduce Fas Ligand expression and degranulation in T helper 17 cells leading to activation induced cell death resistance,” Oncotarget, vol. 7, no. 34, pp. 54339–54359, 2016.
View at: Publisher Site | Google Scholar
D. Chun-ling, H. Gao, H. Jin-Meng et al., “Effect of Kuntai Capsule on ovarian function and reproductive function in rats with experimental premature ovarian failure,” Drug Evaluation Research, vol. 42, no. 10, pp. 1942–1949, 2019.
View at: Google Scholar
C. J. Dai, H. Gao, J. M. Hou, Q. Zhang, and W. J. Xu, “Effect of Kuntai capsule on Fas, FasL protein and mRNA expression in rats with premature ovarian railure,” Pharmacology and Clinics of Chinese Materia Medica, vol. 35, no. 02, pp. 123–128, 2019.
View at: Google Scholar
W. Dan and X. D. Zhang, “Effects of guizhi fuling capsules on the levels of sex hormone and the apoptosis of ovarian cells in rats with premature ovarian failure,” Western Journal of Traditional Chinese Medicine, vol. 33, pp. 24–29, 2020.
View at: Google Scholar
X. F. Sun, S. W. Yang, Y. S. He, C. Chen, L. M. Gong, and L. Luo, “Effect of zuogui Pill on the expression of gap junction protein 43 in ovarian tissue of mice with chemotherapy-induced premature ovarian failure,” China Pharmacy, vol. 28, no. 22, pp. 3044–3047, 2017.
View at: Google Scholar
L. Xin-Peng, Effect of Bushen Tiaochong Recipe on SCF and Cx37 in Rats with Premature Ovarian Failure Induced by Tripterygium Wilfordi, North China University of Technology, Beijing, China, 2018.
L. I. Xiang and L. I. Jia, “Effects of kunbao pills on premature ovarian failure in rats,” Journal of Guangzhou University of Traditional Chinese Medicine, vol. 38, pp. 1949–1954, 2021.
View at: Google Scholar
L. Jia, “Clinical study on Siwu mixture for premature ovarian failure in adjuvant treatment,” New Chinese Medicine, vol. 51, pp. 175–177, 2019.
View at: Publisher Site | Google Scholar
W. Hong-Bo, Experimental Study to Explore the Mechanism of Aromatase Activity and Expression in Cisplatin-Injured Ovarian Granulosa Cells Based on the TGFβ3 Pathway by the Intervention of a Combination of Four Substances, Beijing University of TCM, Beijing, China, 2017.
C. Ya-Meng, H. Gao, and W. J. Xu, “Influences of Kuntai capsules on ovarian GDF-9 and Egr-1 in rats with diminished ovarian reserve function due to cyclophosphamide,” Shanxi Journal of Traditional Chinese Medicine, vol. 34, pp. 47–51, 2018.
View at: Google Scholar
S.-P Chen, To Explore the Effects of Kuntai Capsule on POI Rats Based on TGF-Β/smads Signaling Pathway, Nanjing University of TCM, Nanjing, China, 2019.
L. Zhu, Y. Q. Zhang, P. E. N. G. Yan-li et al., “Effect of zuogui Pill on GDF-9/smad2 signal transduction in premature ovarian failure model mice,” Chinese Journal of Integrated Traditional and Western Medicine, vol. 37, no. 11, pp. 1367–1371, 2017.
View at: Google Scholar
M. J. Yu, T. Li-Li, and A. H. Wu, “Effect and mechanism of kidney-tonifying and sperm-filling on primitive follicle development in mice via Bmp4/Smad signaling pathway,” Lishizhen Medicine and Materia Medica Research, vol. 31, pp. 280–282, 2020.
View at: Google Scholar
L. Hui-Ping, Z. Liu-Ting, and L. J. Hu, “Effects of Bushen Huoxue Recipe on the expressions of TGF-β1, TGF-βRII and Smad2/3 in granulosa cells in mice with premature ovarian failure,” Chinese Traditional Patent Medicine, vol. 39, pp. 1782–1788, 2017.
View at: Google Scholar
J. W. Christman, R. T. Sadikot, and T. S. Blackwell, “The role of nuclear factor-kappa B in pulmonary diseases,” Chest, vol. 117, no. 5, pp. 1482–1487, 2000.
View at: Publisher Site | Google Scholar
M. Zhou, X. Yu, and M. Hui, “Effects of erxian decoction on serum inflammatory factor, related growth factor and sex hormone levels in rats with premature ovarian failure,” Chinese Archives of Traditional Chinese Medicine, vol. 39, pp. 240–243, 2021.
View at: Google Scholar
T. Liu, S. N. Yin, and X. Luan, “Effect of Cistanche on the expressions of immune factor and apoptosis-related proteins in ovaries of rats with premature ovarian failure,” The Chinese Journal of Clinical Pharmacology, vol. 35, no. 23, pp. 3084–3087, 2019.
View at: Google Scholar
L. I. Lan, Z. Da-yuan, and K. F. Yang, “Therapeutic effect and protection mechanism of Yiqi Yangrong fujing formula in mice with CTX-induced premature ovarian failure,” Information on Traditional Chinese Medicine, vol. 38, no. 11, pp. 47–52, 2021.
View at: Google Scholar
W. J. Xu, Study on the Correlation between Bushen Tiaochong Recipe on Prevention and Cure of Premature Ovarian Failure Induced by Tripterysium Glycosides, North China University of Technology, Beijing, China, 2017.
W. J. Xu, H. Gao, and L. I. Yang, “Changes in serum sex hormone levels and ovarian tissue VEGF and bFGF protein expression in rats with premature ovarian failure by gavage with kidney tonifying and toning formula,” Shandong Medical Journal, vol. 56, no. 47, pp. 41–43, 2016.
View at: Google Scholar
W. J. Xu, H. Gao, and L. I. Yang, “Effect of Yan Kuntai capsule on rat sex hormone level and VEGF bFGF mRNA expression in different stages and premature ovarian failure,” Chongqing Medicine, vol. 46, no. 06, pp. 738–741, 2017.
View at: Google Scholar
K. Xiong, L. Tan, and A. I. B. Wang, “Progress on anti-oxidation mechanisms and antioxidants of the keap1-nrf2/ARE signaling pathway,” Progress in Veterinary Medicine, vol. 42, pp. 89–94, 2021.
View at: Google Scholar
K. Taguchi, H. Motohashi, and M. Yamamoto, “Molecular mechanisms of the Keap1–Nrf2 pathway in stress response and cancer evolution,” Genes to Cells, vol. 16, no. 2, pp. 123–140, 2011.
View at: Publisher Site | Google Scholar
K. Ma, Y. Yuan, and H. X. Zhang, “Clinical efficacy of Bushen Culuan Decoction in treating infertility due to premature ovarian insufficiency,” China Journal of Chinese Materia Medica, vol. 44, no. 6, pp. 1075–1079, 2019.
View at: Publisher Site | Google Scholar
C. Yan-Xia, The Mechanism of Bushen Culuan Decoction in the Protection of Diminished Ovarian Reserve via Modulating PI3K and Nrf2 Pathway, China Academy, 2020.
Y. E. Yu-Zhi, X. Wang, and M. Liu, “Anti-peroxidation effects of yiguanjian on rat model of premature ovarian failure,” Chinese Archives of Traditional Chinese Medicine, vol. 34, no. 10, pp. 2431–2434, 2016.
View at: Google Scholar
D. Wu and Z. De-Qiu, “Role of SIRT1 in cardiovascular diseases,” Central South Pharmacy, vol. 19, no. 12, pp. 2609–2615, 2021.
View at: Google Scholar
L. Tong, L. Jin-Li, and L. L. Sun, “Preventive effects of Zuogui Pills and Yougui Pills on ovarian aging of premature ovarian failure mice,” Chinese Traditional Patent Medicine, vol. 39, pp. 260–265, 2017.
View at: Google Scholar

Copyright

Copyright © 2022 Yidi Wang et al. This is an open access article distributed under the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.

PDF Download Citation

Download other formats

Order printed copies

Views

492

Downloads

663

Citations